Print this page
• Back to Web version of article
Index of Articles From AIDSinfo
In English
- Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States (PDF) (April 29, 2009)
To download PDA version, click here.
- Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States: Tables (PDF) (April 29, 2009)
To download PDA version, click here.
- HIV and Its Treatment: What You Should Know (December 2008)
Health information for patients.
To read PDF, click here.
- Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF) (November 3, 2008)
To download PDA version, click here.
- What's New in the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (November 3, 2008)
- Table 6: Antiretroviral Therapy for Treatment-Naive Patients (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 7: Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 8: Antiretroviral Components Not Recommended as Initial Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 9: Antiretroviral Regimens or Components That Should Not Be Offered at Any Time (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 12: Strategies to Improve Adherence to Antiretroviral Therapy (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 13: Antiretroviral Therapy-Associated Adverse Effects and Management Recommendations (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 14: Drugs That Should Not Be Used With PI, NNRTI, or CCR5 Antagonist Antiretrovirals (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15a: Drug Interactions Between Protease Inhibitors (PIs) and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15b: Drug Interactions Between NNRTIs and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15c: Drug Interactions Between NRTIs and Other Drugs (Including Antiretroviral Agents) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 15d-e: Drug Interactions Between CCR5 Antagonists, Integrase Inhibitors and Other Drugs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 16a: Interactions Among Protease Inhibitors (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Table 16b: Interactions between NNRTIs, Maraviroc, and PIs (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 2: Characteristics of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 3: Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Table 4: Characteristics of Protease Inhibitors (PIs) (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Appendix Tables 5-7: Characteristics of Fusion and Integrase Inhibitors and CCR5 Antagonists (PDF) (November 3, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents.
- Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (PDF) (July 29, 2008)
To download PDA version, click here.
- Supplement I: Pediatric Antiretroviral Drug Information (PDF) (July 29, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- DHHS Adults and Adolescents Antiretroviral Treatment Guidelines Panel's Communication Regarding Abacavir (April 4, 2008)
To read PDF, click here.
- Supplement II: Managing Complications of HIV Infection in HIV-Infected Children on Antiretroviral Therapy (PDF) (February 28, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- Supplement III: Adverse Drug Effects (PDF) (February 28, 2008)
Supplement to the pediatric guidelines; to download PDA version, click here.
- HIV During Pregnancy, Labor and Delivery, and After Birth (January 2008)
Health information for HIV-positive pregnant women.
To read PDF, click here.
- Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy (PDF) (November 2, 2007)
Supplement to the perinatal guidelines; to download PDA version, click here.
- Entecavir in Hepatitis B Virus (HBV)/HIV Co-Infected Patients (April 30, 2007)
Supplement to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents -- October 10, 2006
To read PDF, click here.
- Update on the New York City "Superbug" (August 11, 2006)
- Antiretroviral Formulations (PDF) (August 2006)
- Recommended Immunizations for HIV-Positive Adults (June 2006)
To read PDF, click here.
- Recommendations for Non-HIV-Specialized Providers Caring for Displaced HIV-Infected Residents from the Hurricane Disasters (September 23, 2005)
To read PDF, click here.
- What Is an HIV/AIDS Clinical Trial? (September 2005)
To read PDF, click here.
- The HIV Life Cycle (May 2005)
To read PDF, click here.
- Hyperglycemia (May 2005)
To read PDF, click here.
- Lipodystrophy (May 2005)
To read PDF, click here.
- Skin Rash (May 2005)
To read PDF, click here.
- Osteonecrosis, Osteopenia and Osteoporosis (May 2005)
To read PDF, click here.
- Hepatotoxicity (May 2005)
To read PDF, click here.
- Lactic Acidosis (May 2005)
To read PDF, click here.
- Hyperlipidemia (May 2005)
To read PDF, click here.
- FDA Approves Generic Formulation of Didanosine (ddI) Delayed Release Capsules (December 3, 2004)
- Glossary of HIV/AIDS-Related Terms (June 1999)
To read PDF, click here.
- Suggestions for Taking the Liquid Formulation of Ritonavir (August 21, 1998)
- HIV Protease Inhibitors & You (December 1997)
- Developing Options for Perinatal HIV Prevention in the Developing World (June 1997)
- Understanding Viral Load (March 1997)
- Caring for Someone With AIDS at Home: A Guide
En Español
You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art12774.html
General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.